TippingPoint

Epigeneitc medicine for brain cancer

Human 3 criteria:

AI enabled

Step change

TippingPoint is a UCSF spinout that has developed a first-in-class screening platform to generate a better understanding of how the epigenome (how our DNA is packaged) drives and maintains disease. This platform has the potential applications in central nervous system disorders including Alzheimer’s disease, brain cancers, and more.

Under the radar for now - more info soon.

2024

XEIA invests

Want more from XEIA?

Stay up to date on Human 3 - the new epoch of health, wellbeing and performance

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.
Thank you! You've been added to our mailing list.
Oops! Something went wrong while submitting the form.
X-disciplinary Exploration, Investment & Acceleration

© 2025 XEIA Venture Partners, LLC